Abiopharma

(30% Negative) APPLIED INDUSTRIAL TECHNOLOGIES INC (AIT) Reports Q3 2026 Financial Results

OdysightAI Second Quarter 2026 Financial Results

📋 Hochman Kevin (Officer) plans to sell 40K shares of BRINKER INTERNATIONAL, INC (at $248.76 each, total $10.0M) Filed: Aug 13, 2026 | ID: 005959

Financial Statements and Related Announcement: Half Yearly Results

New Form SCHEDULE 13G/A - Janux Therapeutics, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001274173-26-000200 <b>Size:</b> 13 KB

New Form SCHEDULE 13G/A - Bicara Therapeutics Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001274173-26-000198 <b>Size:</b> 12 KB

New Form SCHEDULE 13G/A - FLEX LTD. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001274173-26-000199 <b>Size:</b> 13 KB

New Form SCHEDULE 13G/A - BEL FUSE INC /NJ <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001274173-26-000197 <b>Size:</b> 12 KB

New Form SCHEDULE 13G/A - Ocugen, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001274173-26-000196 <b>Size:</b> 12 KB

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039828 <b>Size:</b> 564 KB

Asset Acquisitions and Disposals: Announcement pursuant to Rule 706A of the Listing Manual

Oceania Cruises® Spotlights Longer Voyages as the Ultimate Way to Explore the World

Financial Statements and Related Announcement: Third Quarter Results

New Form SCHEDULE 13G/A - Enveric Biosciences, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001493152-26-037652 <b>Size:</b> 12 KB

Eizenman Liron 🔴 sold 169.7K shares (3 derivative) of SILICOM LTD. (SILC) at $48.53 ($2.7M) Transaction Date: Aug 12, 2026 | Filing ID: 004110